RARS1 and neoplasm: 9-cis RA (9-cis-13,14-dihydroretinic acid) is a potential activator of RARs and RXRs, which has been uncovered to inhibit tumor progression (Gottardis et al., 1996; Christov et al., 2002; Karsy et al., 2010).